Bevacizumab + INF-α-2a: safer and therefore less costly in mRCC Clinical study 17 January 2013 Pages: 1 - 1
Oral aspirin appears to be effective for preventing severe skin burning related to tacrolimus ointment use Clinical study 17 January 2013 Pages: 2 - 2
New adverse cardiovascular events have been identified from the RE-LY* trial after a review of study data Clinical study 17 January 2013 Pages: 2 - 2
Bisphosphonate-induced fractures: just how atypical are they? Meeting report 17 January 2013 Pages: 3 - 4
The US FDA has been criticised for its handling of the investigation into the contaminated heparin crisis.* News item 17 January 2013 Pages: 4 - 4
No concern for unexpected viral DNA in live attenuated vaccines Media release 17 January 2013 Pages: 4 - 4
The US FDA is warning consumers against the use of Vigor-25, a natural dietary supplement promoted for sexual enhancement Media release 17 January 2013 Pages: 4 - 4
